These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 16528025)

  • 1. Characterization and immunological analysis of the rhesus cytomegalovirus homologue (Rh112) of the human cytomegalovirus UL83 lower matrix phosphoprotein (pp65).
    Yue Y; Kaur A; Zhou SS; Barry PA
    J Gen Virol; 2006 Apr; 87(Pt 4):777-787. PubMed ID: 16528025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and protective efficacy of DNA vaccines expressing rhesus cytomegalovirus glycoprotein B, phosphoprotein 65-2, and viral interleukin-10 in rhesus macaques.
    Yue Y; Kaur A; Eberhardt MK; Kassis N; Zhou SS; Tarantal AF; Barry PA
    J Virol; 2007 Feb; 81(3):1095-109. PubMed ID: 17108040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice.
    Chiuppesi F; Nguyen J; Park S; Contreras H; Kha M; Meng Z; Kaltcheva T; Iniguez A; Martinez J; La Rosa C; Wussow F; Diamond DJ
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30045984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A heterologous DNA prime/protein boost immunization strategy for rhesus cytomegalovirus.
    Abel K; Strelow L; Yue Y; Eberhardt MK; Schmidt KA; Barry PA
    Vaccine; 2008 Nov; 26(47):6013-25. PubMed ID: 18760319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of HLA-G-restricted human cytomegalovirus pp65 (UL83)-specific cytotoxic T lymphocytes in HLA-G transgenic mice.
    Lenfant F; Pizzato N; Liang S; Davrinche C; Le Bouteiller P; Horuzsko A
    J Gen Virol; 2003 Feb; 84(Pt 2):307-317. PubMed ID: 12560562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additive Protection against Congenital Cytomegalovirus Conferred by Combined Glycoprotein B/pp65 Vaccination Using a Lymphocytic Choriomeningitis Virus Vector.
    Schleiss MR; Berka U; Watson E; Aistleithner M; Kiefmann B; Mangeat B; Swanson EC; Gillis PA; Hernandez-Alvarado N; Fernández-Alarcón C; Zabeli JC; Pinschewer DD; Lilja AE; Schwendinger M; Guirakhoo F; Monath TP; Orlinger KK
    Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27795301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus pp65 limits dissemination but is dispensable for persistence.
    Malouli D; Hansen SG; Nakayasu ES; Marshall EE; Hughes CM; Ventura AB; Gilbride RM; Lewis MS; Xu G; Kreklywich C; Whizin N; Fischer M; Legasse AW; Viswanathan K; Siess D; Camp DG; Axthelm MK; Kahl C; DeFilippis VR; Smith RD; Streblow DN; Picker LJ; Früh K
    J Clin Invest; 2014 May; 124(5):1928-44. PubMed ID: 24691437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.
    Wills MR; Carmichael AJ; Mynard K; Jin X; Weekes MP; Plachter B; Sissons JG
    J Virol; 1996 Nov; 70(11):7569-79. PubMed ID: 8892876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The next generation recombinant human cytomegalovirus vaccine candidates-beyond gB.
    Lilja AE; Mason PW
    Vaccine; 2012 Nov; 30(49):6980-90. PubMed ID: 23041121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection.
    Gibson L; Piccinini G; Lilleri D; Revello MG; Wang Z; Markel S; Diamond DJ; Luzuriaga K
    J Immunol; 2004 Feb; 172(4):2256-64. PubMed ID: 14764694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody responses to rhesus cytomegalovirus glycoprotein B in naturally infected rhesus macaques.
    Yue Y; Zhou SS; Barry PA
    J Gen Virol; 2003 Dec; 84(Pt 12):3371-3379. PubMed ID: 14645918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo stimulation and expansion of both CD4(+) and CD8(+) T cells from peripheral blood mononuclear cells of human cytomegalovirus-seropositive blood donors by using a soluble recombinant chimeric protein, IE1-pp65.
    Vaz-Santiago J; Lulé J; Rohrlich P; Jacquier C; Gibert N; Le Roy E; Betbeder D; Davignon JL; Davrinche C
    J Virol; 2001 Sep; 75(17):7840-7. PubMed ID: 11483727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Cytomegalovirus Tegument Protein pp65 (pUL83) Dampens Type I Interferon Production by Inactivating the DNA Sensor cGAS without Affecting STING.
    Biolatti M; Dell'Oste V; Pautasso S; Gugliesi F; von Einem J; Krapp C; Jakobsen MR; Borgogna C; Gariglio M; De Andrea M; Landolfo S
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Functional Characterization of a Novel Fc Gamma-Binding Glycoprotein in Rhesus Cytomegalovirus.
    Kolb P; Sijmons S; McArdle MR; Taher H; Womack J; Hughes C; Ventura A; Jarvis MA; Stahl-Hennig C; Hansen S; Picker LJ; Malouli D; Hengel H; Früh K
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30487278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Construction and transfection of eucaryotic expression recombinant vector containing truncated region of UL83 gene of human cytomegalovirus and it's sheltered effect as DNA vaccine].
    Gao RB; Li YQ; Wang ML
    Wei Sheng Wu Xue Bao; 2006 Jun; 46(3):451-5. PubMed ID: 16933619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine-induced control of viral shedding following rhesus cytomegalovirus challenge in rhesus macaques.
    Abel K; Martinez J; Yue Y; Lacey SF; Wang Z; Strelow L; Dasgupta A; Li Z; Schmidt KA; Oxford KL; Assaf B; Longmate JA; Diamond DJ; Barry PA
    J Virol; 2011 Mar; 85(6):2878-90. PubMed ID: 21191005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection.
    Wang Z; La Rosa C; Lacey SF; Maas R; Mekhoubad S; Britt WJ; Diamond DJ
    J Clin Virol; 2006 Mar; 35(3):324-31. PubMed ID: 16388983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity evaluation of DNA vaccines that target guinea pig cytomegalovirus proteins glycoprotein B and UL83.
    Schleiss MR; Bourne N; Jensen NJ; Bravo F; Bernstein DI
    Viral Immunol; 2000; 13(2):155-67. PubMed ID: 10892996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inconsistent responses of cytomegalovirus-specific T cells to pp65 and IE-1 versus infected dendritic cells in organ transplant recipients.
    Lilleri D; Zelini P; Fornara C; Comolli G; Gerna G
    Am J Transplant; 2007 Aug; 7(8):1997-2005. PubMed ID: 17617865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralization of rhesus cytomegalovirus IL-10 reduces horizontal transmission and alters long-term immunity.
    Deere JD; Chang WLW; Villalobos A; Schmidt KA; Deshpande A; Castillo LD; Fike J; Walter MR; Barry PA; Hartigan-O'Connor DJ
    Proc Natl Acad Sci U S A; 2019 Jun; 116(26):13036-13041. PubMed ID: 31189602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.